These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Indications for hemo- and peritoneal dialysis]. Kuhlbäck B Munch Med Wochenschr; 1966 Aug; 108(31):1547-52. PubMed ID: 4865844 [No Abstract] [Full Text] [Related]
46. Neurobehavioral responses to "middle molecule" dialysis and transplantation. Teschan PE; Ginn HE; Bourne JR; Ward JW Trans Am Soc Artif Intern Organs; 1976; 22():190-4. PubMed ID: 781978 [No Abstract] [Full Text] [Related]
47. Statistical support for or against transplantation. Lange H; Hoffmann RA; Himmelmann G Am Heart J; 1979 Jun; 97(6):808-10. PubMed ID: 373407 [No Abstract] [Full Text] [Related]
48. Outcome of therapy for end-stage uremia: an informed prediction of survival rate and degree of rehabilitation. Gutman RA; Amara AH Postgrad Med; 1978 Nov; 64(5):183-94. PubMed ID: 362400 [No Abstract] [Full Text] [Related]
49. Involution of polycystic kidneys during active treatment of terminal uremia. Thaysen JH; Christensen E; Alarcon-Zurita A; Movild B Acta Med Scand; 1975 Apr; 197(4):257-60. PubMed ID: 1094807 [TBL] [Abstract][Full Text] [Related]
51. [Treatment of uremia in the Languedoc-Roussillon région: 1965-1979]. Mirouze J; Mion C Bull Acad Natl Med; 1979 May; 163(5):415-9. PubMed ID: 15648331 [No Abstract] [Full Text] [Related]
52. [Therapeutic problems with transplantation receivers]. Enderlin F Bull Schweiz Akad Med Wiss; 1970 Jun; 26(1):54-69. PubMed ID: 4395551 [No Abstract] [Full Text] [Related]
53. Relation of hypertriglyceridaemia to kidney transplant dysfunction and rejection, and response to antilymphocyte globulin therapy. Charlesworth JA; Edwards KD Prog Biochem Pharmacol; 1974; 9():107-20. PubMed ID: 4612555 [No Abstract] [Full Text] [Related]
54. [Renal transplantation in insulin-dependent diabetic patients]. Beaudry C; Bracelo R; Cardinal J; Carrière S; Dandavino R; Friborg J; Houde M; Laplante L; Bastien E; Girard R Union Med Can; 1981 Mar; 110(3):221-8. PubMed ID: 7018044 [No Abstract] [Full Text] [Related]
55. The clinical significance of adynamic bone disease in uremia. Fournier A; Said S; Ghazali A; Sechet A; Ezaitouni F; Marie A; Westeel PF; Morinière P; Boudailliez B Adv Nephrol Necker Hosp; 1997; 27():131-66. PubMed ID: 9408446 [No Abstract] [Full Text] [Related]
56. [The treatment of chronic uremia]. Fritzer W; Jahn O; Pinggera W Wien Klin Wochenschr; 1967 Jun; 79(23):432-4. PubMed ID: 4874053 [No Abstract] [Full Text] [Related]
57. Eight years' experience with a community dialysis center: the Northwest Kidney Center. Pendras JP; Pollard TL Trans Am Soc Artif Intern Organs; 1970; 16():77-84. PubMed ID: 4916743 [No Abstract] [Full Text] [Related]
58. [The local authorities faced with the complex problems of the treatment of chronic uremic patients]. Matuella S Minerva Chir; 1979 Nov; 34(21):1441-2. PubMed ID: 399664 [No Abstract] [Full Text] [Related]
59. [The rehabilitation of the uremic child]. Gordillo-Paniagua G Bol Med Hosp Infant Mex; 1981; 38(3):401-5. PubMed ID: 7023498 [No Abstract] [Full Text] [Related]